Paul is a 30-year veteran driving business development in biotech, specialising in in vitro diagnostics for infectious diseases. Hs is an Australian representative for Geneva-based Global Antibiotic R&D partnership (GARDP), member of the Investment Committee at Horizon 3 Biotech Fund, and strategic advisor to Alsonex, Marinova and other Australian biotech companies. Prior he was the Life Sciences Senior Investment Specialist at Australian trade and investment agency, Austrade.
Paul Field
